These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18701532)

  • 1. Secondary prevention of cardiovascular disease in different primary healthcare systems with and without pay-for-performance.
    Cupples ME; Byrne MC; Smith SM; Leathem CS; Murphy AW
    Heart; 2008 Dec; 94(12):1594-600. PubMed ID: 18701532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice.
    Connolly P; Cupples ME; Cuene-Grandidier H; Johnston D; Passmore P
    Pharmacoepidemiol Drug Saf; 2002 Jun; 11(4):311-7. PubMed ID: 12138599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived and reported access to the general practitioner: an international comparison of universal access and mixed private/public systems.
    Galway KJ; Murphy AW; O'Reilly D; O'Dowd T; O'Neill C; Shryane E; Steele K; Bury G; Gilliland A; Kelly A
    Ir Med J; 2007 Jun; 100(6):494-7. PubMed ID: 17668682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress and morale in general practice: a comparison of two health care systems.
    Gilliland AE; Sinclair H; Cupples ME; McSweeney M; Mac Auley D; O'Dowd TC
    Br J Gen Pract; 1998 Oct; 48(435):1663-7. PubMed ID: 10071399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk reduction: impact of an international project].
    Colle B; Brusaferro S;
    Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
    Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and comorbid conditions among Black South Africans with hypertension in public and private primary care settings: the HiHi study.
    Dennison CR; Peer N; Lombard CJ; Kepe L; Levitt NS; Steyn K; Hill MN
    Ethn Dis; 2007; 17(3):477-83. PubMed ID: 17985501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP).
    Lauritzen T; Jensen MS; Thomsen JL; Christensen B; Engberg M
    Scand J Public Health; 2008 Aug; 36(6):650-61. PubMed ID: 18775821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study of secondary cardiac care in general practice: impact of personal and practice characteristics.
    Byrne M; Murphy AW; Walsh JC; Shryane E; McGroarty M; Kelleher CC
    Fam Pract; 2006 Jun; 23(3):295-302. PubMed ID: 16585129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital infection society prevalence survey of Healthcare Associated Infection 2006: comparison of results between Northern Ireland and the Republic of Ireland.
    Fitzpatrick F; McIlvenny G; Oza A; Newcombe RG; Humphreys H; Cunney R; Murphy N; Ruddy R; Reid G; Bailie R; Lavelle C; Doherty L; Smyth ET
    J Hosp Infect; 2008 Jul; 69(3):265-73. PubMed ID: 18547678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care.
    van Steenkiste B; van der Weijden TM; Stoffers JH; GROL RP
    Patient Educ Couns; 2008 Jul; 72(1):63-70. PubMed ID: 18395393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerable older people in the community: relationship between the Vulnerable Elders Survey and health service use.
    McGee HM; O'Hanlon A; Barker M; Hickey A; Montgomery A; Conroy R; O'Neill D
    J Am Geriatr Soc; 2008 Jan; 56(1):8-15. PubMed ID: 18184202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive practices for adult cardiovascular disease in children.
    Kluger CZ; Morrison JA; Daniels SR
    J Fam Pract; 1991 Jul; 33(1):65-72. PubMed ID: 2056292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results.
    Cooney MT; Storey S; Taylor L; Dudina A; Hall M; Hemeryck L; Feely J; Graham I
    Ir Med J; 2009 Apr; 102(4):113-6. PubMed ID: 19552291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease risk management in a primary health care setting of north India.
    Kar SS; Thakur JS; Jain S; Kumar R
    Indian Heart J; 2008; 60(1):19-25. PubMed ID: 19212017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular prevention, primary or secondary, in high risk patients].
    Richard JL; Delahaye F
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1495-502. PubMed ID: 9891833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.